Use of On-Q Pump for Pain Post C-Section

• Status: Completed
• Trial end date: 2019-07-25
• Target enrollment: 0
• Participant gender: Female

Summary

The main purpose of this study is to examine if pain levels treated with intrathecal (IT) preservative-free morphine (PFM) after a cesarean section improve with the additional use of continuous subfascial wound infiltration with ropivacaine using the OnQ® elastomeric pump system.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Emory University
• Treatments: Ropivacaine

Criteria

Inclusion Criteria:

1. Female patients at Emory University Hospital Midtown undergoing non-emergent, scheduled or unscheduled first, second or third Cesarean sections

2. Patients who are American Society of Anesthesiology (ASA) Class I-III

3. Patients are at least 34 weeks pregnant

4. Patients to receive spinal anesthesia for their procedure

5. Patients who are 18 years of age or older

6. Patient willing and able to provide written informed consent

Exclusion Criteria:

1. Patients with 3 or more prior Cesarean sections

2. Patients undergoing emergent cesarean section with or without general anesthesia

3. Patients with known allergy to morphine, ketorolac, and/or amide local anesthetics

4. Patients who will not receive spinal anesthesia

5. Patients who are less than 34 weeks pregnant

6. Patients with significant maternal cardiac, liver or renal disease

7. Patients with maternal history of narcotic abuse or dependency

8. Patient with pre-operative fever (>100.4 degrees F)

9. Patients less than 18 years old